Company / Accounts Receivable
SS Innovations International, Inc. Accounts Receivable History
FY2022-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Accounts Receivable
$12.4M
FY2025
5-year range
$592.3K / $12.4M
FY2022-FY2025
Trend
+177.6%
vs FY2024
Sector context
#134 of 138
Health Care
What the data says
Among 138 Health Care companies, SS Innovations International, Inc. is in the bottom 3% for accounts receivable. Accounts Receivable has increased for 3 consecutive years, from $592,313 in FY2022 to $12M in FY2025.
Based on SEC 10-K filings.
$12M in FY2025 with a 3-year CAGR of +175.6%.
Improved from $2M to $12M over the past 2 years.
Health Care sector context is included.
Accounts Receivable over time
Growth rates
- 3-Year CAGR
- +175.6%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 3% in Health CareTop 97% of 138This company $12.4M Sector average $1.3B
▼
-99.1% below sector average
Key checks
Key Insights
- SS Innovations International, Inc.'s accounts receivable has grown for 3 consecutive years.
- 3-year CAGR of +175.6%, indicating consistent growth.
- In FY2025, accounts receivable increased 177.6% year-over-year.
- Ranks #134 out of 138 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score 0.26 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Accounts ReceivableValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $12.4M | +177.6% |
| FY2024 | $4.5M | +134.9% |
| FY2023 | $1.9M | +221.0% |
| FY2022 | $592.3K | - |
| FY2021 | - | - |
| FY2020 | - | - |
| FY2019 | - | - |
| FY2018 | - | - |
| FY2017 | - | - |
| FY2016 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026